Bioteque Corporation Statistics
Bioteque Corporation (4107) Stock Statistics & Valuation Metrics
Total Valuation
Bioteque Corporation has a market cap or net worth of TWD 7.21B. The enterprise value is TWD 6.62B.
- Market Cap
- TWD 7.21B
- Enterprise Value
- TWD 6.62B
Share Statistics
Bioteque Corporation has 69,298,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 69,298,330
- Owned by Insiders
- ―
- Owned by Institutions
- 2.37%
Financial Efficiency
Bioteque Corporation’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.54%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 12.54%
- Return on Capital Employed (ROCE)
- 0.16
- Revenue Per Employee
- 5.55M
- Profits Per Employee
- 1.40M
- Employee Count
- 385
- Asset Turnover
- 0.46
- Inventory Turnover
- 4.07
Valuation Ratios
The current PE Ratio of Bioteque Corporation is 12.53. Bioteque Corporation’s PEG ratio is 1.03.
- PE Ratio
- 12.53
- PS Ratio
- 3.32
- PB Ratio
- 2.09
- Price to FCF
- 12.48
- Price to Operating Cash Flow
- 10.57
- PEG Ratio
- 1.03
Income Statement
In the last 12 months, Bioteque Corporation had revenue of 2.14B and earned 539.18M in profits. Earnings per share was 7.78.
- Revenue
- 2.14B
- Gross Profit
- 936.93M
- Operating Income
- 670.28M
- Pretax Income
- 674.62M
- Net Income
- 539.18M
- EBITDA
- 841.83M
- Earnings Per Share (EPS)
- 7.78
Cash Flow
In the last 12 months, operating cash flow was 697.95M and capital expenditures -106.53M, giving a free cash flow of 591.42M billion.
- Operating Cash Flow
- 697.95M
- Free Cash Flow
- 591.42M
- Free Cash Flow per Share
- 8.54
Dividends & Yields
Bioteque Corporation pays an annual dividend of ―, resulting in a dividend yield of 5.29%
- Dividend Per Share
- ―
- Dividend Yield
- 5.29%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.05%
- Earnings Yield
- 8.03%
Stock Price Statistics
- Beta
- 0.22
- 52-Week Price Change
- -15.10%
- 50-Day Moving Average
- 109.76
- 200-Day Moving Average
- 112.05
- Relative Strength Index (RSI)
- 28.14
- Average Volume (3m)
- 44.45K
Important Dates
Bioteque Corporation upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 07, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Bioteque Corporation as a current ratio of 4.27, with Debt / Equity ratio of 16.56%
- Current Ratio
- 4.27
- Quick Ratio
- 3.73
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.67
- Interest Coverage Ratio
- 88.88
Taxes
In the past 12 months, Bioteque Corporation has paid 135.44M in taxes.
- Income Tax
- 135.44M
- Effective Tax Rate
- 0.20
Enterprise Valuation
Bioteque Corporation EV to EBITDA ratio is 7.52, with an EV/FCF ratio of 11.52.
- EV to Sales
- 3.07
- EV to EBITDA
- 7.52
- EV to Free Cash Flow
- 11.52
- EV to Operating Cash Flow
- 9.76
Balance Sheet
Bioteque Corporation has TWD 1.87B in cash and marketable securities with TWD 499.42M in debt, giving a net cash position of TWD 1.37B billion.
- Cash & Marketable Securities
- TWD 1.87B
- Total Debt
- TWD 499.42M
- Net Cash
- TWD 1.37B
- Net Cash Per Share
- TWD 19.79
- Tangible Book Value Per Share
- TWD 50.92
Margins
Gross margin is 44.96%, with operating margin of 32.46%, and net profit margin of 26.54%.
- Gross Margin
- 44.96%
- Operating Margin
- 32.46%
- Pretax Margin
- 33.86%
- Net Profit Margin
- 26.54%
- EBITDA Margin
- 40.81%
- EBIT Margin
- 32.92%
Analyst Forecast
The average price target for Bioteque Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.16%
- EPS Growth Forecast
- 17.15%
